Phase 4 Type 1 Diabetes Trial, Recruiting NCT07159282 Sponsor: Applied Biologics, LLC Condition: Type 1 Diabetes
Back to Type 1 Diabetes

Phase 4 Type 1 Diabetes Trial, Recruiting

NCT07159282
Recruiting Phase 4

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are 18 years of age or older.
  • People who have been diagnosed with type 1 or type 2 diabetes.
  • People who have more than one foot ulcer, where the ulcer being treated in this trial is the same one that was treated in the previous CAMPX study.
  • People who are willing to use the prescribed pressure-relief method (such as a special boot or cast) for the full duration of the study.
  • People who are able to attend weekly study visits as required.
  • People who are able to understand and agree to the consent process for joining a study.
  • People who took part in the CAMPX trial, were placed in the standard care only group, and whose ulcer had not fully healed by the 12-week mark.

Who may not be able to join:

  • People who are expected to live fewer than 6 months.
  • People whose foot ulcer is not caused by diabetes.
  • People whose ulcer is currently infected, or where the surrounding skin shows signs of infection (confirm with trial site).
  • People whose ulcer is deep enough to expose a tendon or bone.
  • People who show signs of a bone infection connected to the ulcer.
  • People who have an infection — either in the ulcer or elsewhere in the body — that requires antibiotic tablets or injections.
  • People who are taking immune-suppressing medicines, high-dose steroid tablets (above a certain daily dose), chemotherapy, or other medicines that the trial doctor believes could slow wound healing.
  • People who have applied steroid cream or ointment directly to the ulcer within the past month.
  • People who have had a partial amputation on the affected foot that makes it difficult to properly relieve pressure on the ulcer.
  • People whose blood sugar control measure (HbA1c) was 12% or higher within the past 3 months.
  • People who have an active or inactive Charcot foot condition (a serious foot bone disorder) that makes it difficult to properly relieve pressure on the ulcer.
  • Women who are pregnant or planning to become pregnant within the next 6 months.
  • People who have end-stage kidney disease and require dialysis.
  • People who, in the trial doctor's opinion, have a medical or psychological condition that may affect study results.
  • People who score below 17 on a standard nutrition assessment tool, indicating significant malnutrition.
  • People who did not take part in the CAMPX trial.
  • People who took part in the CAMPX trial but were not placed in the standard care only group.
  • People who took part in the CAMPX trial and whose ulcer fully healed during that study.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Phone: 1-833-865-6300

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 4
Sponsor
Applied Biologics, LLC
Registry
ClinicalTrials.gov
Start date
26 August 2025
Est. completion
1 August 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Wound Closure

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov